Retinal Implant Market By Type | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Retinal Implant Market
Retinal Implant Market: By Type (Epiretinal Implants, Subretinal Implants, and Suprachoroidal Implants), By Drug Type (Argus II, Implantable Telescope, and Alpha IMS), & By Region-Forecast (2016-2021)
Report Code : HCR 0370
Updated Date: 22 September, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Retinal Implant Market – Market Overview
2. Executive Summary 
3. Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Retinal Implant Market– Market Forces
   4.1. Drivers
      4.1.1. Development of efficient and advance technology
      4.1.2. Growing geriatric population and prevalence of degenerative conditions
   4.2. Restraints
      4.2.1. Higher cost of research and development 
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Retinal Implant Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Retinal Implant Market, By Type
   6.1. Epiretinal Implants
   6.2. Subretinal Implants
   6.3. Suprachoroidal Implants
7. Retinal Implant Market, By Drug Type 
   7.1. Argus II
   7.2. Implantable Telescope
   7.3. Alpha IMS
8. Retinal Implant Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America 
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Retinal Implant – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Second Sight Medical Products, Inc.
   10.2. Retina Implant AG
   10.3. VisionCare Ophthalmic Technologies, Inc
   10.4. Bionic Eye Technologies, Inc.
   10.5. Visus Technology, Inc
   10.6. Bionic Vision Australia
   10.7. Abbott Vascular
   10.8. Dräger Medical GmbH 
   10.9. Hamilton Medical AG
   10.10. Philips Healthcare
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Retinal implants, also known as a bionic eye are biomedical microchips designed to provide visual perception to people suffering from degenerative eye diseases such as retinitis pigmentosa and age-related macular degeneration and have lost vision.  Globally, development of efficient and advance technology, rise in the awareness among people retinal implant, increasing government initiative across the globe, growing geriatric population and prevalence of degenerative conditions are the prime growth drivers of global retinal implant market. In addition, increase in adoption of retinal implant in emerging economies such as China, India and others, will create new opportunities for retinal implant market. However, higher cost of the research and development, risk of biocompatibility and long-term stability of the material used for devising retinal implants, complex nature of implant surgeries, lack of trained professionals, and higher cost of surgeries are the key restraints for retinal implant market.

 Retinal Implant Market

Geographically North America dominated retinal implant market because of advanced and well setup health care infrastructure, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, increasing population of patients suffering from age-related macular degeneration (AMD) and retinitis pigmentosa (RP), rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the device type, Implantable Miniature Telescope (IMT) has the highest market share in global retinal implant market.

This report identifies the global retinal implant market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global retinal implant market.

This report segments global retinal implant market on the basis of type, drug type, and regional market as follows:
  • Retinal Implant Market, By Type: Epiretinal Implants, Subretinal Implants, and Suprachoroidal Implants
  • The report has focused study on retinal implant market by basis of device type such as: Argus II, Implantable Telescope, and Alpha IMS
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the retinal implant market. Some of the major companies’ profiles in detail are as follows:
  • Second Sight Medical Products, Inc.
  • Retina Implant AG
  • VisionCare Ophthalmic Technologies, Inc
  • Bionic Eye Technologies, Inc.
  • Visus Technology, Inc
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports